| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.087 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |